INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 436s ago
HOUSE PTR16s ago
SEC 13F9s ago
ROBINHOOD CHAIN3s ago
Corporate insider
BJ

Bluestone Jeffrey

DirectorCIK 0001771814

EDGAR filingsOpen in network
Disclosed transactions18
Buys / sells0 / 7
Max Insider Score35
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
2
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$79K
1,165 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    GILEAD SCIENCES, INC.Director · Dec 1, 2025
8
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL
$167K
1,165 sh
Aug 20, 2026
Aug 21, 2026
traded Aug 20, 2026
+1d
SEC FORM 4

Evidence

2
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$122K
1,816 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

11
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$263K
1,816 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

2
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$112K
1,658 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

8
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$242K
1,658 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

0
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$1,754
26 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

1
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$3,805
26 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

0
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$21K
335 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

1
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$49K
335 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

0
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M—
4,665 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

0
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M—
335 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

13
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$337K
5,000 sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC FORM 4

Evidence

25
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$618K
5,000 sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC FORM 4

Evidence

0
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M—
5,000 sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC FORM 4

Evidence

21
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise
M—
5,000 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC FORM 4

Evidence

27
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise
M$325K
5,000 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC FORM 4

Evidence

35
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Open-market sale
SELL$625K
5,000 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC FORM 4

Evidence